Department of Psychiatry, Graduate School of Medicine, Showa University, Shinagawa-ku, Tokyo, Japan.
Department of Psychiatry, School of Medicine, Showa University, Shinagawa-ku, Tokyo, Japan.
Neuropsychopharmacol Rep. 2024 Sep;44(3):620-630. doi: 10.1002/npr2.12465. Epub 2024 Jul 15.
The prevalence of obesity is increasing worldwide, resulting in various health issues such as hypertension, dyslipidemia, diabetes mellitus, heart disease, and a lower life expectancy. Importantly, several psychiatric disorders and the use of psychotropic medications have been linked to obesity, and the possible risk factors need further investigation. This study examined the prevalence of obesity and its associated factors using a self-administered questionnaire. Participants were recruited from three outpatient clinics and individuals who met one or more of the ICD-10 F0-F9, G4 diagnoses were included. In total, 1384 participants completed the questionnaire about their lifestyle. Statistical analysis compared the demographic and clinical characteristics of the individuals who were obese (Body Mass Index: BMI ≥25) and those who were non-obese (BMI <25). The results revealed that the factors associated with obesity in psychiatric outpatients were being male, prolonged treatment duration, eating out frequently, and use of both second- and first-generation antipsychotics. The study emphasized the importance of closely monitoring BMI in individuals with multiple obesity-related factors.
肥胖症在全球范围内的流行率不断上升,导致了各种健康问题,如高血压、血脂异常、糖尿病、心脏病和预期寿命降低。重要的是,一些精神疾病和精神药物的使用与肥胖有关,需要进一步研究可能的风险因素。本研究使用自我管理问卷检查了肥胖症的流行率及其相关因素。参与者是从三个门诊诊所招募的,包括符合一个或多个 ICD-10 F0-F9、G4 诊断标准的个体。共有 1384 名参与者完成了关于他们生活方式的问卷。统计分析比较了肥胖者(身体质量指数:BMI≥25)和非肥胖者(BMI<25)的人口统计学和临床特征。结果表明,精神科门诊患者肥胖的相关因素为男性、治疗时间延长、经常外出就餐以及同时使用第二代和第一代抗精神病药物。该研究强调了在具有多种肥胖相关因素的个体中密切监测 BMI 的重要性。